Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2008
09/04/2008US20080213842 Kit for synthesizing polynucleotides
09/04/2008US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders
09/04/2008US20080213823 Using capillaray pressure and multicomparment apparatus to separate and measure concentration of cell in fluid mixture
09/04/2008US20080213822 Methods for diagnosing celiac sprue and reagents useful therein
09/04/2008US20080213821 Multicompartment optical apparatus for separation of preferential cells in fluids; medical sorting and diagnosis
09/04/2008US20080213820 Using channel protein activation as evaluative tool in determining concentration of muscle contration antagonist; diagnosing smooth muscle disorders
09/04/2008US20080213819 Multizonal apparatus for sedimentation and recovery of erythrocytes
09/04/2008US20080213818 Cellular immunity test with peptides attached to a solid support
09/04/2008US20080213817 Enhancement of Th2-Dependent and Inflammatory Response
09/04/2008US20080213816 Mitochondrial enoyl coenzyme a hydratase 1 as marker for diagnosing stomach cancer
09/04/2008US20080213815 Diagnosing breast cancer by seprase level
09/04/2008US20080213814 Enzymatic assay for lspr
09/04/2008US20080213813 Histone deacetylase inhibitor and use thereof
09/04/2008US20080213812 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
09/04/2008US20080213811 Sensor proteins and assay methods
09/04/2008US20080213810 Identifying modulators of human immunodeficiency viral infection; viricides
09/04/2008US20080213809 Coenzyme substrates; kits; nicotinamide adenine dinucleotide; biochemical detection
09/04/2008US20080213808 Nicotinamide-dependent oxidoreductase, reducible nicotinamide coenzyme, quinone-based mediator such as 1,7-phenanthrolinequinone derivative; kits
09/04/2008US20080213807 Methods of Using Bone Morphogenic Proteins as Biomarkers for Determining Cartilage Degeneration and Aging
09/04/2008US20080213805 Method for Distinguishing Follicular Thyroid Adenoma (FTA) from Follicular Thyroid Carcinoma (FTC)
09/04/2008US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia
09/04/2008US20080213802 Diagnosis of Neurodegenerative Diseases
09/04/2008US20080213800 Method for Examing Interstitital Cystitis
09/04/2008US20080213796 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
09/04/2008US20080213793 Antibodies that bind receptor protein designated 2f1
09/04/2008US20080213792 Homogeneous Multiplex Screening Kits
09/04/2008US20080213791 Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
09/04/2008US20080213790 Method for synthesizing polynucleotides
09/04/2008US20080213789 Detecting DNA 5'-methylation at cytosine residue of a CpG site via specific primer extension
09/04/2008US20080213788 Using presence of amino acid substitution in dehydratase as evaluative tool in prediciting fungicidal resistance in rice crops
09/04/2008US20080213787 Using the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry to identify polymorphism in killer cell immunoglobulin-like receptor (KIR) genotype for use in diagnosis of cancer and immune disorders
09/04/2008US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders
09/04/2008US20080213785 Using haptoglobin phenotypes as evaluative tool in prediciting efficacy vitamin-e in treating cardiovascular disorders
09/04/2008US20080213784 Screening methods and sequences relating thereto
09/04/2008US20080213783 Binding oxidoreductases, peroxidases with oxidation/reduction agents; immunohistochemistry; kits
09/04/2008US20080213782 SOCS-1 Gene Methylation in Cancer
09/04/2008US20080213781 Using CpG island specific probes to enhance detection of cell proliferative disorders
09/04/2008US20080213780 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
09/04/2008US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders
09/04/2008US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
09/04/2008US20080213777 Using malignant brain tumor (MBT) repeat protein (LIN-61) as tool in identifying modulators for prevention and treatment of cell proliferative disorders
09/04/2008US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
09/04/2008US20080213775 Using presence of variation in methylenetetrahydrofolate dehydrogenase as evaluative tool in diagnosis/prognosis of pregnancy-related disorders
09/04/2008US20080213774 Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors
09/04/2008US20080213773 Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
09/04/2008US20080213772 Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
09/04/2008US20080213771 Methods and Compositions for Large-Scale Analysis of Nucleic Acids Using DNA Deletions
09/04/2008US20080213770 Using polymerase with reduced exonuclease activity as replicative agent in DNA sequencing
09/04/2008US20080213769 Apparatus for monitoring chromosomal abnormalities; diagnosing cell proliferative disorders; bioinformatics
09/04/2008US20080213768 Identification and use of biomarkers for non-invasive and early detection of liver injury
09/04/2008US20080213767 Detection Of Nucleic Acids By Target-Catalyzed Product Formation
09/04/2008US20080213766 Method and device for detecting the presence of a single target nucleic acid in samples
09/04/2008US20080213765 Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof
09/04/2008US20080213764 Human Protooncogene and Protein Encoded Therein
09/04/2008US20080213763 For diagnosing cancers including leukemia, uterine cancer, lymphoma, colon cancer, lung cancer, and skin cancer
09/04/2008US20080213762 Method of Gene Sequence Examination
09/04/2008US20080213761 Using G-protein coupled receptors to identify modulators of flavors; enhancing drug and food palatability
09/04/2008US20080213760 Compositions and methods for protein isolation
09/04/2008US20080213759 Novel Angiogenesis Inhibitor
09/04/2008US20080213758 Method For Estimating End Use Qualities of Wheat at Growth Stage
09/04/2008US20080213757 Methods of Distinguishing Types of Spinal Neurons Using Corl1 Gene as an Indicator
09/04/2008US20080213756 Real-Time Pcr Point Mutation Assays For Detecting Hiv - 1 Resistance to Antiviral Drugs
09/04/2008US20080213755 Apparatus which utilizes cyclic DNA propagation for determining genotype of preferential samples
09/04/2008US20080213754 Method of Amplifying Atp and Use Thereof
09/04/2008US20080213753 Method for the verification of the removal of viruses to validate filters and filtering processes
09/04/2008US20080213752 Bacteriophages as Selective Agents
09/04/2008US20080213751 Ilcs based pattern recognition of sepsis
09/04/2008US20080213750 HCV Variants and Related Methods
09/04/2008US20080213749 Oligonucleotide sequence primers for use in amplification of viral genome sequences; viral disease; diagnosing respiratory system infection
09/04/2008US20080213748 Automated high throughput bioassay for diagnostics; electrophoretic complexing of microbial proteins; electron or light microscopy
09/04/2008US20080213747 Fluorescent dyes for use as reporter molecules in detection of preferential particles, cells and/or organisms in sample
09/04/2008US20080213745 Biomarkers Of Metabolic Responses To Hepatotoxicants And Carcinogens
09/04/2008US20080213744 Method of Determining Hypoxia
09/04/2008US20080213743 Modifying settling velocity of fluid component by addition of anticoagulant agents
09/04/2008US20080213694 Acid generator mixture is a diphenyl iodinium mesylate, tosylate or perfluorobutylsulfonate salt, a nonionic fluoroaliphatic polymer ester surfactant and N-methylpyrrolidone; solid phase synthesis of DNA, RNA, peptide nucleic acids, locked nucleic acids, or proteins for chips; photolithography
09/04/2008US20080213404 Hif Modulating Compounds and Methods of Use Thereof
09/04/2008US20080213387 Isolated cytotrophoblast stem cell expresses HLA-G and HLA class I antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; Cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy
09/04/2008US20080213319 Using chemorepellents and unimodal fugetaxins as therapeutic tool in treatment of cell proliferative disorders
09/04/2008US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
09/04/2008US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders
09/04/2008US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
09/04/2008US20080213284 Receptor binding polypeptides
09/04/2008US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders
09/04/2008US20080213270 Using concentration of preferential neurotransmitter as diagnostic indicator of enterotoxin infection
09/04/2008US20080213258 Method of Predicting and Reducing Risk of Metastasis of Breast Cancer to Lung
09/04/2008US20080213250 Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases
09/04/2008US20080213247 Mbms as Modifiers of Branching Morphogenesis and Methods of Use
09/04/2008US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy
09/04/2008US20080213240 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
09/04/2008US20080213237 Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof
09/04/2008US20080213231 Self-renewing progenitor cells for use in treating cardiac disease; tissue engineering; tissue repair; regenerative medicine
09/04/2008US20080213230 Pluripotent cell culture for propagation of cardiac tissues and treatment of myocardial infarction; tissue engineering; tissue repair; regenerative medicine
09/04/2008US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
09/04/2008US20080213214 Treating Cardiovascular Tissue
09/04/2008US20080213211 Compositions and methods for healthy pregnancy
09/04/2008US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
09/04/2008US20080212880 Identification and Classification of Virus Particles in Textured Electron Micrographs
09/04/2008US20080212400 System for Agitating the Fluid Contents of A Container
09/04/2008US20080210631 Purified enzyme having an activity in the MTBE degradation path; novel bacterial strain Mycobacterium austroafricanum; bioremediation of water contamination
09/04/2008US20080210573 Multiplexed electrochemical detection system and method